tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RYTM Stock Latest News

Rhythm Pharmaceuticals price target raised to $145 from $140 at BofA
The FlyRhythm Pharmaceuticals price target raised to $145 from $140 at BofA
5d ago
RYTM
Rhythm Pharmaceuticals: Raising Revenue Forecasts and Price Target on Strengthening BBS Growth and Clear aHO Catalyst Path
PremiumRatings
Rhythm Pharmaceuticals: Raising Revenue Forecasts and Price Target on Strengthening BBS Growth and Clear aHO Catalyst Path
7d ago
RYTM
Rhythm Pharmaceuticals Reports Strong Preliminary 2025 IMCIVREE Revenue
PremiumCompany Announcements
Rhythm Pharmaceuticals Reports Strong Preliminary 2025 IMCIVREE Revenue
7d ago
8K
RYTM
Rhythm Pharmaceuticals Sees Q4 IMCIVREE product revenue $57M
PremiumThe Fly
Rhythm Pharmaceuticals Sees Q4 IMCIVREE product revenue $57M
7d ago
RYTM
Rhythm Pharmaceuticals announces anticipated upcoming milestones
PremiumThe Fly
Rhythm Pharmaceuticals announces anticipated upcoming milestones
7d ago
RYTM
Rhythm Pharmaceuticals: Early Promising PWS Data and Robust MC4R Pipeline Support Buy Rating and $140 Target
PremiumRatingsRhythm Pharmaceuticals: Early Promising PWS Data and Robust MC4R Pipeline Support Buy Rating and $140 Target
25d ago
RYTM
Rhythm Pharmaceuticals price target raised to $123 from $110 at H.C. Wainwright
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $123 from $110 at H.C. Wainwright
26d ago
RYTM
Rhythm Pharmaceuticals Announces Resignation of Board Member Bedrosian
Premium
Company Announcements
Rhythm Pharmaceuticals Announces Resignation of Board Member Bedrosian
28d ago
8K
RYTM
Rhythm Pharmaceuticals price target raised to $140 from $120 at Guggenheim
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $140 from $120 at Guggenheim
1M ago
RYTM
Rhythm Pharmaceuticals price target raised to $157 from $141 at Goldman Sachs
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $157 from $141 at Goldman Sachs
1M ago
RYTM
Promising Clinical Results and Market Potential Drive Buy Rating for Rhythm Pharmaceuticals
PremiumRatings
Promising Clinical Results and Market Potential Drive Buy Rating for Rhythm Pharmaceuticals
1M ago
RYTM
Rhythm Pharmaceuticals price target raised to $141 from $114 at Canaccord
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $141 from $114 at Canaccord
1M ago
RYTM
Rhythm Pharmaceuticals price target raised to $167 from $141 at Citizens
PremiumThe FlyRhythm Pharmaceuticals price target raised to $167 from $141 at Citizens
1M ago
RYTM
Palatin initiated with a Buy at LaidlawRhythm Pharmaceuticals
Premium
The Fly
Palatin initiated with a Buy at LaidlawRhythm Pharmaceuticals
1M ago
PTN
RYTM
Promising Phase 2 Results for Rhythm Pharmaceuticals’ Setmelanotide in Prader-Willi Syndrome Boost Buy Rating
Premium
Ratings
Promising Phase 2 Results for Rhythm Pharmaceuticals’ Setmelanotide in Prader-Willi Syndrome Boost Buy Rating
1M ago
RYTM
Rhythm Pharmaceuticals price target raised to $150 from $129 at Morgan Stanley
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $150 from $129 at Morgan Stanley
1M ago
RYTM
Rhythm Pharmaceuticals rises 15.6%
PremiumThe Fly
Rhythm Pharmaceuticals rises 15.6%
1M ago
RYTM
Positive Phase 2 Trial Results Boost Rhythm Pharmaceuticals’ Outlook and Price Target
PremiumRatings
Positive Phase 2 Trial Results Boost Rhythm Pharmaceuticals’ Outlook and Price Target
1M ago
RYTM
Rhythm Pharmaceuticals price target raised to $140 from $127 at BofA
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $140 from $127 at BofA
1M ago
RYTM
Rhythm Pharmaceuticals rises 11.4%
PremiumThe FlyRhythm Pharmaceuticals rises 11.4%
1M ago
RYTM
Rhythm Pharmaceuticals Announces Positive Phase 2 Trial Results
Premium
Company Announcements
Rhythm Pharmaceuticals Announces Positive Phase 2 Trial Results
1M ago
8K
RYTM
Rhythm Pharmaceuticals’ setmelanotide shows efficacy in Phase 2 PWS trial
Premium
The Fly
Rhythm Pharmaceuticals’ setmelanotide shows efficacy in Phase 2 PWS trial
1M ago
RYTM

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >